Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 21, 2017; 23(47): 8376-8386
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8376
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8376
Figure 1 Relationship between the tumor-associated neutrophil-to-lymphocyte ratio and tumor recurrence.
A: Representative immunohistochemical staining for CD15 (left) and CD8 (right); B: Significant differences in the TA-NLR were observed between the recurrence group (0.46% ± 0.05%, mean ± SE) and the non-recurrence group (0.24% ± 0.03%, P < 0.001). TA-NLR: Tumor-associated neutrophil-to-lymphocyte ratio.
- Citation: Cao LL, Lu J, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Chen QY, Lin M, Tu RH, Huang CM. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms. World J Gastroenterol 2017; 23(47): 8376-8386
- URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8376.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8376